Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts: Gene/Protein Disease Symptom Drug Enzyme Compound   Target Concepts: Gene/Protein Disease Symptom Drug Enzyme Compound

---

Query: UMLS:C0011849 (diabetes)
277,896 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The adhesion of leukocytes to endothelium is a physiological phenomenon which is the first step for leukocyte emigration. The adhesion can be dramatically increased in pathological situations such as inflammation and vascular diseases. The molecular basis of leukocyte-endothelium interaction has been largely investigated in the last ten years. Using monoclonal antibodies it is possible to characterize the leukocyte adhesion molecule (LeuCAM) also named CD11/CD18 complex. These molecules responsible for leukocyte adhesion are heterodimers consisting of a common beta subunit and different subunit CD11a/CD18 corresponding to LFA-1; CD11b/CD18 to Mac1/Mol; CD11c/CD18 to GP150-95. Beside these receptors, other leukocyte structures such as the fibronectin receptors are involved in the adhesive process. On the endothelial cell side specialized structures implicated in leukocyte adhesion have been identified. Structures like Intercellular Adhesion Molecule (ICAM) are expressed on endothelial cells in the absence of stimulation, while other receptors Endothelial Leukocyte Adhesion Molecule (ELAM) are only detectable on activated endothelial cells. Cytokines such as IL-1 induced the expression of ELAM, increased the number of ICAM and Human Leukocyte Antigens (HLA) DR, DP, DQ. In various pathological circumstances, namely extracorporeal circulation, Acute Respiratory Distress Syndrome (ARDS), hypercholesterolemia and diabetes mellitus increased leukocyte adhesion has been reported and is potentially responsible for vascular damage. Therefore, the modulation of leukocyte-endothelial cell interactions is a possible target for antithrombotic and antiatherosclerotic therapy.
...
PMID:Leukocyte adhesion to endothelial cells. 226 8

To identify events and mechanisms that might contribute to the poor reversibility of diabetic complications, we examined whether diabetes or high glucose induces changes in gene expression and whether such changes outlast the presence of the metabolic abnormalities. The study focused on fibronectin because the increased amounts of this glycoprotein found in diabetic tissues and thickened basement membranes are as yet unexplained. In streptozotocin-induced diabetic rats, fibronectin mRNA levels were increased to 304 +/- 295% of control (mean +/- SD) in the kidney cortex (P less than 0.02), and to 271 +/- 273% of control in the heart (P less than 0.02), while actin mRNA levels remained unchanged. Elevation of fibronectin mRNA persisted for weeks after restoration of near-normoglycemia. In cultured human endothelial cells, high glucose-induced overexpression of fibronectin and collagen IV remained detectable after replating and multiple cell divisions in the absence of high glucose. Cells shifted to normal-glucose medium after prolonged exposure to high glucose also exhibited a proliferative advantage over cells chronically maintained in normal glucose. Thus, diabetes increases fibronectin expression in tissues that are known targets of the complications, and the effect is not readily reversible. The in vitro studies suggest that hyperglycemia may be responsible for these events through induction of self-perpetuating changes in gene expression.
...
PMID:Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. 229 96

Diabetic nephropathy is a major cause of the increased morbidity and mortality in insulin-dependent diabetes mellitus. The most significant renal lesion of diabetic nephropathy is expansion of the glomerular mesangium. Thickening of the glomerular basement membrance is also apparent. Mesangial expansion is largely due to the accumulation of extracellular matrix (ECM) proteins such as fibronectin, laminin, and type IV collagen. To determine whether high glucose is responsible for the observed increase in mesangial cell ECM protein accumulation, mesangial cells were grown in tissue culture medium containing 10 mmol/l (millimolar) glucose (normal) or 30 mmol/l glucose (high). The degree of ECM protein accumulation was determined by immunocytochemistry and a solid-phase enzyme-linked immunosorbent assay (ELISA) developed in the laboratory. Mesangial cells cultured for 1 week contained fibronectin as the most abundant ECM protein, followed by laminin and type IV collagen. Type IV collagen was seen only after the cells had piled up into 'hillocks' (approximately 4 weeks of continuous growth without passaging). After 4 weeks in 30 mmol/l glucose, mesangial cells contained increased amounts of all three matrix proteins. Fibronectin and laminin were increased by approximately 60%, while type IV collagen was increased 50%. Cells subcultured in medium containing 30 mmol/l glucose for 8 months displayed a twofold increase in fibronectin and laminin. Thus, high glucose per se can cause changes in mesangial cell ECM. This cell culture model should be useful in elucidating the mechanisms involved.
...
PMID:High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. 235 64

Immunoelectrophoresis was used to measure fibronectin content in blood plasma of 111 children with insulin-dependent diabetes mellitus and in 20 normal children. In patients with diabetes mellitus, the content of plasma fibronectin turned out to be higher depending on the disease standing, the presence of microangiopathies, and status of compensation. It has been noted that fibronectin was detectable in urine in diabetic angionephropathy.
...
PMID:[Clinico-diagnostic significance of fibronectin determination in diabetes mellitus in children]. 239 32

Platelets hyperaggregability and hypersecretion fibronectin (Fn) are known to occur in peripheral vascular disease (PVD) and diabetes mellitus (DM) with microangiopathy. To determine whether an increase in platelet membrane bound Fn constitutes to hyperaggregability of platelets, washed platelets from normal subjects and from patients with peripheral vascular disease and patients with diabetes mellitus were examined for the presence of fibronectin (Fn) by means of fluorescein linked antibody to Fn. Platelets from peripheral vascular disease and diabetes mellitus patients tended to aggregate during preparation and apparently exhibited greater fluorescence in platelet "smears" than was observed in smears from controls. In contrast, when washed platelet "smears" were prepared from platelet preparations containing iloprost, an analogue of prostacyclin, platelet aggregates did not form and the 'excess' of fluorescence disappeared from all the three groups. When platelets were stained for Fn fluorescence in suspensions, no fluorescence was observed on the surface of platelets from peripheral vascular disease and diabetes mellitus patients or controls. On stimulation with thrombin washed platelet suspension showed fluorescence for Fn. Platelet activation leads to Fn appearing on platelet surface but this effect cannot be quantified by optical fluorescence microscopy.
...
PMID:A study of platelet fibronectin immunofluorescence in peripheral vascular disease and diabetes mellitus. 248 53

Excess production of growth hormone (GH) in poorly controlled diabetes is believed to be a causal factor in the development of diabetic angiopathy, the mechanism(s) of which is unknown. The present study was undertaken to determine whether exogenous growth hormone would specifically change some quantities and functional parameters known to often be abnormal in long-standing diabetes and thought to result from the development of vascular lesions in general. The authors studied capillary resistance, factor VIII coagulant antigen (F VIII:Ag), von Willebrand factor (vWf:Ag), fibronectin, fibrinogen, and tissue-type plasminogen activator (t-PA) before, during, and after 1 week's subcutaneous GH administration (6 IU per day divided into two doses). Capillary resistance decreased insignificantly, but returned to higher levels (p less than 0.05) 1 week after withdrawal. F VIII:Ag, vWf:Ag, fibronectin, and fibrinogen all increased significantly during GH treatment. Except for F VIII:Ag, these quantities returned to pre-medication levels 7 days after termination of GH administration. The present results may contribute to the clarification of the role of GH hypersecretion in diabetic microangiopathy and macroangiopathy.
...
PMID:Diabetes-like alterations in hemostatic parameters after growth hormone administration for one week in normal man. 252 35

Annulus fibrosus of intervertebral discs from diabetic and non-diabetic sand rats were examined by microspectrophotometry for fibronectin content. This was higher in the diabetic animals both in the dorsal and ventral parts and in the outer and inner lamellae of the annulus. It is suggested that diabetes-related changes in fibronectin are similar to changes in annular collagen observed in species other than sand rats.
...
PMID:Fibronectin content of the annulus fibrosus in diabetic and non-diabetic sand rats. 269 55

To obtain data concerning the pathology of diabetic arteries, aortas from 23 patients with diabetes mellitus [9 with insulin-dependent diabetes mellitus (IDDM) and 14 with non-insulin-dependent diabetes mellitus (NIDDM)] were collected at autopsy together with aortas from sex- and age-matched nondiabetic persons. A histomorphometric study was performed blindly on antifibronectin PAP-stained sections to determine the distribution of fibronectin-containing space in the vessels. In both IDDM and nonIDDM groups a statistically significant increase of approximately 45% was seen in the amount of stainable material in the tunica media. The increase was not influenced by the presence or absence of overlying plaque. No differences were seen between diabetic and nondiabetic vessels in the tunica intima. The content of extractable fibronectin in intima-media preparations was measured. The samples were extracted sequentially with buffered saline, a heparin-urea solution, and finally collagenase digestion. Fibronectin measured in these extracts showed that statistically significantly more of this glycoprotein was found in vessels from diabetic persons compared with nondiabetic persons, when comparing areas of the vessels without macroscopical visible plaque. However, only among IDDM patients increased amounts were apparent in plaque areas. These results indicate that diabetic patients develop structural alterations in the connective tissue of their arteries, consistent with a hypothesis of a diabetic macroangiopathy.
...
PMID:Accumulation of fibronectin in aortas from diabetic patients. A quantitative immunohistochemical and biochemical study. 279 91

Treatment of human glomerular basement membrane (GBM) with 4 M guanidine HCl resulted in a preferential extraction of noncollagenous components including laminin, fibronectin, entactin, and heparan sulfate proteoglycan, whereas effective solubilization of type IV collagen required exposure to denaturing solvents in the presence of reducing agents. The guanidine HCl-solubilized constituents were identified by immunochemical procedures after resolution by polyacrylamide gel electrophoresis, CL-6B filtration, and DEAE-cellulose chromatography. Two immunologically related heparan sulfate proteoglycans (Mr approximately 350,000 and 210,000) were observed by electrophoresis, with the higher-molecular-weight form being predominant. An examination of the two proteoglycans after heparitinase digestion or chemical deglycosylation indicated that heparan sulfate chains and other carbohydrate units are attached to core proteins with Mr approximately 140,000 and 110,000, respectively. Radioimmunoassays indicated that human diabetic GBM contained significantly lower (P less than .005) amounts of heparan sulfate proteoglycan and laminin with average values that were 30 and 60%, respectively, of nondiabetic controls; the fibronectin content of the diabetic GBM, however, was not significantly different from the normal. These findings, together with previous studies showing increases in GBM collagen, indicate that an alteration in the macromolecular architecture of this basement membrane occurs in diabetes that may be responsible for the filtration defect and the ultimate glomerular occlusion.
Diabetes 1987 Mar
PMID:Studies on macromolecular components of human glomerular basement membrane and alterations in diabetes. Decreased levels of heparan sulfate proteoglycan and laminin. 294 55

Diabetic nephropathy develops in many diabetic patients as consequence of glomerulosclerosis. On the basis of a series of recent observations it is suggested that a combination of metabolic and hemodynamic changes is responsible for the pathogenesis of diabetic nephropathy. Since the glomerular filtration unit has been characterized to consist of collagen type IV and minor components like laminin, fibronectin and heparan sulfate proteoglycan, influence of diabetes on basement membrane (BM) components has been studied. Biochemical alterations of glomerular BM consist of an increased nonenzymatic glucosylation of type IV collagen leading to unphysiological crosslinking. This, in turn, may result in alteration of the size selective properties of the glomerular filtration unit. Changes in composition of glomerular BM have recently been described. An increased synthesis of type IV collagen with concomitant decrease of heparan sulfate proteoglycan may lead to alteration of the charge selective barrier and consequently to increased permeability of the glomerular BM. Permanently unbalanced synthesis of BM components finally results in obliteration of the capillary lumen. In late state nephropathy intrinsic basement membrane components are no longer produced. Instead, massive accumulation of PAS positive material occurs.
...
PMID:Pathobiochemical aspects of diabetic nephropathy. 297 77


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>

---